Lehman Brothers made a big loan to a medical consulting firm owned by Tokyo-based biotech firm LTT Bio-Pharma. The money was meant to finance hospitals buying medical equipment; it was backed by Marubeni Corp., a big trading firm, according to the New York Post. But payments were never made and Marubeni soon claimed that the documents guaranteeing the loan were forged. This is an embarrassment that could costs Lehman hundreds of millions of dollars at a time when management is under the microscope. The scam is being blamed on rogue traders within Marubeni. Ouch!  

For more:
- here's the New York Post article

Related Articles:
Lehman Brothers still faces antsy markets. Article
Repo man starting to strain? Lehman an issue? Article